Literature DB >> 11938857

[Clinical study on treatment of infantile rotaviral enteritis with Psidium guajava L].

L Wei1, Z Li, B Chen.   

Abstract

OBJECTIVE: To observe the clinical effect of olium Psidium guajava (PG) in treating infantile rotaviral enteritis.
METHODS: Sixty-two patients of rotaviral enteritis were randomly divided into the treated group treated with PG and the control group treated with Gegen Qinlian decoction. The time for ceasing diarrhea, the content of Na+ in blood, the content of Na+ and glucose in stool, and the rate of negative conversion of human rotavirus (HRV) antigen were observed.
RESULTS: The rate of recovery in 3 days of the treated group was 87.1%, significantly higher than that of the control group (58.1%, P < 0.05). The time of ceasing diarrhea of the treated group (25.1 +/- 9.5 hr) was significantly shorter than that of the control group (38.7 +/- 15.2 hr, P < 0.01). The content of Na+ and glucose in stool was reduced obviously in the treated group, while the reduction in the control group was insignificant, the treated group was superior to the control group significantly (P < 0.05). The rate of negative conversion of HRV in feces of the treated group was 87.1%, significantly better than that of the control (58.1%, P < 0.05).
CONCLUSION: The treatment with PG has good curative effect on infantile rotaviral enteritis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11938857

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Bioactivity determination of methanol and water extracts for roots and leaves of Kenyan Psidium guajava L landraces against pathogenic bacteria.

Authors:  Mercy Liharaka Kidaha; Amos Emitati Alakonya; Aggrey Benard Nyende
Journal:  Springerplus       Date:  2013-12-13

Review 2.  Psidium guajava: A Single Plant for Multiple Health Problems of Rural Indian Population.

Authors:  Poonam G Daswani; Manasi S Gholkar; Tannaz J Birdi
Journal:  Pharmacogn Rev       Date:  2017 Jul-Dec
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.